Literature DB >> 21169662

Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery.

E Gonzalez-Mira1, M A Egea, E B Souto, A C Calpena, M L García.   

Abstract

The purpose of this study was to design and optimize a new topical delivery system for ocular administration of flurbiprofen (FB), based on lipid nanoparticles. These particles, called nanostructured lipid carriers (NLC), were composed of a fatty acid (stearic acid (SA)) as the solid lipid and a mixture of Miglyol(®) 812 and castor oil (CO) as the liquid lipids, prepared by the hot high pressure homogenization method. After selecting the critical variables influencing the physicochemical characteristics of the NLC (the liquid lipid (i.e. oil) concentration with respect to the total lipid (cOil/L (wt%)), the surfactant and the flurbiprofen concentration, on particle size, polydispersity index and encapsulation efficiency), a three-factor five-level central rotatable composite design was employed to plan and perform the experiments. Morphological examination, crystallinity and stability studies were also performed to accomplish the optimization study. The results showed that increasing cOil/L (wt%) was followed by an enhanced tendency to produce smaller particles, but the liquid to solid lipid proportion should not exceed 30 wt% due to destabilization problems. Therefore, a 70:30 ratio of SA to oil (miglyol + CO) was selected to develop an optimal NLC formulation. The smaller particles obtained when increasing surfactant concentration led to the selection of 3.2 wt% of Tween(®) 80 (non-ionic surfactant). The positive effect of the increase in FB concentration on the encapsulation efficiency (EE) and its total solubilization in the lipid matrix led to the selection of 0.25 wt% of FB in the formulation. The optimal NLC showed an appropriate average size for ophthalmic administration (228.3 nm) with a narrow size distribution (0.156), negatively charged surface (-33.3 mV) and high EE (∼90%). The in vitro experiments proved that sustained release FB was achieved using NLC as drug carriers. Optimal NLC formulation did not show toxicity on ocular tissues.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21169662     DOI: 10.1088/0957-4484/22/4/045101

Source DB:  PubMed          Journal:  Nanotechnology        ISSN: 0957-4484            Impact factor:   3.874


  21 in total

1.  Human Growth Hormone Fragment 176-191 Peptide Enhances the Toxicity of Doxorubicin-Loaded Chitosan Nanoparticles Against MCF-7 Breast Cancer Cells.

Authors:  Mahmoud M Habibullah; Syam Mohan; Nabeel Kashan Syed; Hafiz A Makeen; Qazi Mohammad Sajid Jamal; Hani Alothaid; Farkad Bantun; Alaa Alhazmi; Ali Hakamy; Yahia A Kaabi; Ghalia Samlan; Mohtashim Lohani; Neelaveni Thangavel; Mohamed Ahmed Al-Kasim
Journal:  Drug Des Devel Ther       Date:  2022-06-27       Impact factor: 4.319

2.  Enhanced Dermal Delivery of Flurbiprofen Nanosuspension Based Gel: Development and Ex Vivo Permeation, Pharmacokinetic Evaluations.

Authors:  Ayse Nur Oktay; Sibel Ilbasmis-Tamer; Orhan Uludag; Nevin Celebi
Journal:  Pharm Res       Date:  2021-06-04       Impact factor: 4.200

3.  Enhanced alveo pulmonary deposition of nebulized ciclesonide for attenuating airways inflammations: a strategy to overcome metered dose inhaler drawbacks.

Authors:  Hanan M El-Laithy; Amal Youssef; Shereen S El-Husseney; Nesrine S El Sayed; Ahmed Maher
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

4.  Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy.

Authors:  Amalendu P Ranjan; Anindita Mukerjee; Lawrence Helson; Jamboor K Vishwanatha
Journal:  J Nanobiotechnology       Date:  2012-08-31       Impact factor: 10.435

5.  Influence of freeze-drying and γ-irradiation in preclinical studies of flurbiprofen polymeric nanoparticles for ocular delivery using d-(+)-trehalose and polyethylene glycol.

Authors:  Gladys Rosario Ramos Yacasi; María Luisa García López; Marta Espina García; Alexander Parra Coca; Ana Cristina Calpena Campmany
Journal:  Int J Nanomedicine       Date:  2016-08-23

Review 6.  Natural Ergot Alkaloids in Ocular Pharmacotherapy: Known Molecules for Novel Nanoparticle-Based Delivery Systems.

Authors:  Iara Baldim; Wanderley P Oliveira; Varsha Kadian; Rekha Rao; Nitesh Yadav; Sheefali Mahant; Massimo Lucarini; Alessandra Durazzo; Raquel Da Ana; Raffaele Capasso; Selma B Souto; Antonello Santini; Eliana B Souto
Journal:  Biomolecules       Date:  2020-06-30

7.  Excipient-excipient interactions in the development of nanocarriers: an innovative statistical approach for formulation decisions.

Authors:  Viviane Lucia Beraldo-de-Araújo; Anderson Beraldo-de-Araújo; Juliana Souza Ribeiro Costa; Ana Carolina Martins Pelegrine; Lígia Nunes Moraes Ribeiro; Eneida de Paula; Laura Oliveira-Nascimento
Journal:  Sci Rep       Date:  2019-07-24       Impact factor: 4.379

8.  Gefitinib loaded nanostructured lipid carriers: characterization, evaluation and anti-human colon cancer activity in vitro.

Authors:  Hafiz A Makeen; Syam Mohan; Mohamed Ahmed Al-Kasim; Ibraheem M Attafi; Rayan A Ahmed; Nabeel Kashan Syed; Muhammad Hadi Sultan; Mohammed Al-Bratty; Hassan A Alhazmi; Mohammed M Safhi; Raisuddin Ali; M Intakhab Alam
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

9.  Ferulic Acid-Loaded Polymeric Nanoparticles for Potential Ocular Delivery.

Authors:  Alessia Romeo; Teresa Musumeci; Claudia Carbone; Angela Bonaccorso; Simona Corvo; Gabriella Lupo; Carmelina Daniela Anfuso; Giovanni Puglisi; Rosario Pignatello
Journal:  Pharmaceutics       Date:  2021-05-11       Impact factor: 6.321

Review 10.  Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review.

Authors:  Mohamed Haider; Shifaa M Abdin; Leena Kamal; Gorka Orive
Journal:  Pharmaceutics       Date:  2020-03-23       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.